On February 3, 2020, Cohen Mizrahi resigned as a director and as an officer of Bionovate Technologies Corp. Dr. Mizrahi's resignation was not the result of a disagreement between Dr. Mizrahi and company on any matter relating to company's operations, policies or practices. On February 3, 2020, David Magana Gonzalez was appointed as a director to replace Dr. Mizrahi and he was also appointed President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer of company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.00% |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 7 | |
+190.94% | 7.13B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 820M | |
+1.72% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- BIIO Stock
- News Bionovate Technologies Corp
- Bionovate Technologies Corp. Announces Management Changes